CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
123,180,519
Total 13F shares
101,339,025
Share change
+3,618,219
Total reported value
$2,199,165,165
Price per share
$21.70
Number of holders
360
Value change
+$74,610,948
Number of buys
204
Number of sells
171

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2025

As of 30 Jun 2025, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 360 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 101,339,025 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, DEERFIELD MANAGEMENT COMPANY, L.P., GEODE CAPITAL MANAGEMENT, LLC, Fundsmith LLP, GOLDMAN SACHS GROUP INC, and BANK OF AMERICA CORP /DE/. This page lists 361 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
365
Q2 2025 holders
360
Holder diff
-5
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.